Company Filing History:
Years Active: 2019-2022
Title: Yanping Yu: Innovator in Cancer Treatment
Introduction
Yanping Yu is a prominent inventor based in Wexford, PA (US), known for her significant contributions to cancer treatment through innovative methods targeting fusion genes. With a total of 6 patents, her work focuses on advancing therapeutic techniques that can improve patient outcomes in oncology.
Latest Patents
Among her latest patents, Yanping Yu has developed methods for treating cells containing fusion genes by genomic targeting. This invention relates to techniques for treating patients with cancer or premalignant conditions. It is based on the discovery that a genome editing technique specifically targeting a fusion gene can induce cell death in various cancer cells, including hepatocellular cancer cells. Another notable patent involves methods of treating cancers containing fusion genes, particularly focusing on the MAN2A1-FER fusion gene. This invention highlights the use of tyrosine kinase inhibitors targeting the MAN2A1-FER fusion gene, which has shown dramatic improvements in survival rates for animals xenografted with the cancer.
Career Highlights
Yanping Yu is affiliated with the University of Pittsburgh, where she continues her research and development in cancer therapies. Her innovative approaches have positioned her as a key figure in the field of genomic medicine.
Collaborations
Throughout her career, Yanping has collaborated with esteemed colleagues, including Jianhua Luo and George Michalopoulos, contributing to a rich environment of research and innovation.
Conclusion
Yanping Yu's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. Her patents reflect a commitment to improving patient care through advanced scientific techniques.